9/30/2016 12:14:26 PM - Pulled back from its 52-week high with a volume-driven loss on the prior session. Reported earnings +23% on +18% sales revenues for the Jul &#39;16 quarter, below the +25% minimum guideline (C criteria). Found support at its 200 DMA line during its prior consolidation. Has new CEO as of 8/01/16. This Medical - Systems/Equipment firm was dropped from the Featured Stocks list on 4/15/05.<br><hr>9/29/2016 12:25:33 PM - Reported earnings +23% on +18% sales revenues for the Jul &#39;16 quarter, below the +25% minimum guideline (C criteria). Pulling back from its 52-week high following recent gains backed by above average volume. Found support at its 200 DMA line during its prior consolidation. Has new CEO as of 8/01/16. This Medical - Systems/Equipment firm was dropped from the Featured Stocks list on 4/15/05.<br><hr>8/30/2016 12:11:16 PM - Gapped up on the prior session rallying to touch a new 52-week high with a considerable gain backed by +139% above average volume. Found support at its 200 DMA line during its consolidation. Has new CEO as of 8/01/16. Noted with caution in prior mid-day reports - <i>&quot;Reported earnings +26% on +23% sales revenues for the Apr &#39;16 quarter, but fundamental concerns remain. Prior quarterly comparisons had earnings below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). This Medical - Systems/Equipment firm was dropped from the Featured Stocks list on 4/15/05.&quot;</i><br><hr>8/29/2016 12:16:34 PM - Gapped up today rallying to touch a new 52-week high with a considerable gain backed by higher volume. Found support at its 200 DMA line during its consolidation, and it has new CEO as of 8/01/16, since last noted with caution in the 6/08/16 mid-day report - <i>&quot;Reported earnings +26% on +23% sales revenues for the Apr &#39;16 quarter, but fundamental concerns remain. Prior quarterly comparisons had earnings below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). This Medical - Systems/Equipment firm was dropped from the Featured Stocks list on 4/15/05.&quot;</i><br><hr>6/8/2016 11:46:26 AM - Rallying toward its 52-week high with today&#39;s 6th consecutive gain backed by higher volume. Reported earnings +26% on +23% sales revenues for the Apr &#39;16 quarter, but fundamental concerns remain. Prior quarterly comparisons had earnings below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). This Medical - Systems/Equipment firm was dropped from the Featured Stocks list on 4/15/05.<br><hr>3/10/2016 12:15:24 PM - Hitting a new 52-week high with today&#39;s gain. Prior mid-day reports cautioned members - <i>&quot;Reported earnings +21% on +12% sales revenues for the Oct &#39;15 quarter, and fundamental concerns remain. Made gradual progress since noted in the 9/30/15 mid-day report with caution - &#39;Consecutive quarterly comparisons with earnings below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). This Medical - Systems/Equipment firm was dropped from the Featured Stocks list on 4/15/05.&#39;&quot; </i><br><hr>2/29/2016 12:15:01 PM - Rebounding toward its 52-week high with today&#39;s 11th consecutive gain.  The 2/05/16 mid-day report cautioned members - <i>&quot;Reported earnings +21% on +12% sales revenues for the Oct &#39;15 quarter, and fundamental concerns remain. Made gradual progress since noted in the 9/30/15 mid-day report with caution - &#39;Consecutive quarterly comparisons with earnings below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). This Medical - Systems/Equipment firm was dropped from the Featured Stocks list on 4/15/05.&#39;&quot; </i><br><hr>2/5/2016 12:03:54 PM - Met resistance at its 50 DMA line after rebounding from its 200 DMA line.  The 12/10/15 mid-day report cautioned members while hitting its 52-week high - <i>&quot;Reported earnings +21% on +12% sales revenues for the Oct &#39;15 quarter, and fundamental concerns remain. Made gradual progress since noted in the 9/30/15 mid-day report with caution - &#39;Consecutive quarterly comparisons with earnings below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). This Medical - Systems/Equipment firm was dropped from the Featured Stocks list on 4/15/05.&#39;&quot; </i><br><hr>1/11/2016 12:34:06 PM - Sputtering but holding its ground after violating its 50 DMA line when last noted with caution in the 1/04/16 mid-day report. The 12/10/15 mid-day report cautioned members while hitting its 52-week high - <i>&quot;Reported earnings +21% on +12% sales revenues for the Oct &#39;15 quarter, and fundamental concerns remain. Made gradual progress since noted in the 9/30/15 mid-day report with caution - &#39;Consecutive quarterly comparisons with earnings below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). This Medical - Systems/Equipment firm was dropped from the Featured Stocks list on 4/15/05.&#39;&quot; </i><br><hr>1/4/2016 12:25:27 PM - Gapped down today violating its 50 DMA line. Last noted with caution in the 12/10/15 mid-day report while hitting its 52-week high - <i>&quot;Reported earnings +21% on +12% sales revenues for the Oct &#39;15 quarter, and fundamental concerns remain. Made gradual progress since noted in the 9/30/15 mid-day report with caution - &#39;Consecutive quarterly comparisons with earnings below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). This Medical - Systems/Equipment firm was dropped from the Featured Stocks list on 4/15/05.&#39;&quot; </i><br><hr>12/10/2015 12:21:30 PM - Reported earnings +21% on +12% sales revenues for the Oct &#39;15 quarter, and fundamental concerns remain. Hitting another new 52-week high today. Made gradual progress since noted in the 9/30/15 mid-day report with caution - <em>&quot;Consecutive quarterly comparisons with earnings below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). This Medical - Systems/Equipment firm was dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>11/17/2015 12:17:48 PM - Reported earnings +39% on +15% sales revenues for the Jul &#39;15 quarter, but fundamental concerns remain. Hovering near its 52-week high. Made gradual progress since last noted in the 9/30/15 mid-day report with caution - <em>&quot;Consecutive quarterly comparisons with earnings below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). This Medical - Systems/Equipment firm was dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>9/30/2015 12:28:52 PM - Reported earnings +39% on +15% sales revenues for the Jul &#39;15 quarter, but fundamental concerns remain. Rebounded above its 50 DMA line with a considerable gain on the prior session, and now challenging its 52-week high. Found support above its 200 DMA line during its consolidation. Prior mid-day reports repeatedly cautioned - <em>&quot;Consecutive quarterly comparisons with earnings below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). This Medical - Systems/Equipment firm was dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>9/29/2015 12:06:51 PM - Reported earnings +39% on +15% sales revenues for the Jul &#39;15 quarter, but fundamental concerns remain. Rebounding above its 50 DMA line with today&#39;s gain after finding support above its 200 DMA line during its consolidation. Prior mid-day reports cautioned - <em>&quot;Consecutive quarterly comparisons with earnings below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). This Medical - Systems/Equipment firm was dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>9/16/2015 12:22:54 PM - Reported earnings +17% on +18% sales revenues for the Apr &#39;15 quarter, and fundamental concerns remain. Rebounding near its 50 DMA line after finding support at its 200 DMA line during its consolidation. Prior mid-day reports cautioned - <em>&quot;Consecutive quarterly comparisons with earnings below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). This Medical - Systems/Equipment firm was dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>6/9/2015 12:19:53 PM - Reported earnings +17% on +18% sales revenues for the Apr &#39;15 quarter, and fundamental concerns remain. Gapped up today hitting a new 52-week high while clearing an orderly base. Prior mid-day reports cautioned - <em>&quot;Consecutive quarterly comparisons with earnings below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). This Medical - Systems/Equipment firm was dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>6/2/2015 12:17:30 PM - Enduring distributional pressure and sputtering below its 50 DMA line. Due to report Apr &#39;15 earnings on Tuesday, June 9 before the market opens. Reported earnings <strong>+16%</strong> on <strong>+14%</strong> sales revenues for the Jan &#39;15 quarter. Made gradual progress since  noted in the 1/21/15 mid-day report with caution - <em>&quot;Reported earnings <strong>+10%</strong> on <strong>+16%</strong> sales revenues for the Oct &#39;14 quarter, its <strong>7</strong>th consecutive quarterly comparison with earnings below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). This Medical - Systems/Equipment firm was dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>4/21/2015 12:10:05 PM - Found support at its 50 DMA line. Reported earnings <strong>+16%</strong> on <strong>+14%</strong> sales revenues for the Jan &#39;15 quarter. Made gradual progress since last noted in the 1/21/15 mid-day report with caution - <em>&quot;Reported earnings <strong>+10%</strong> on <strong>+16%</strong> sales revenues for the Oct &#39;14 quarter, its <strong>7</strong>th consecutive quarterly comparison with earnings below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). This Medical - Systems/Equipment firm was dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>1/21/2015 12:24:40 PM - Consolidating near its 50 DMA line, holding its ground near that important short-term average since last noted in the 12/24/14 mid-day report with caution - <em>&quot;Reported earnings <strong>+10%</strong> on <strong>+16%</strong> sales revenues for the Oct &#39;14 quarter, its <strong>7</strong>th consecutive quarterly comparison with earnings below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). This Medical - Systems/Equipment firm was dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>12/24/2014 11:18:46 AM - Halted its slide at its 50 DMA line. Endured more distributional pressure since the 12/16/14 mid-day report cautioned members - <em>&quot;Reported earnings <strong>+10%</strong> on <strong>+16%</strong> sales revenues for the Oct &#39;14 quarter, its <strong>7</strong>th consecutive quarterly comparison with earnings below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). This Medical - Systems/Equipment firm was dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>12/16/2014 12:21:45 PM - Retreating from all-time highs and slumping toward its 50 DMA line. Reported earnings <strong>+10%</strong> on <strong>+16%</strong> sales revenues for the Oct &#39;14 quarter, its <strong>7</strong>th consecutive quarterly comparison with earnings below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). This Medical - Systems/Equipment firm was dropped from the Featured Stocks list on 4/15/05.<br><hr>11/11/2014 12:13:11 PM - Holding its ground perched near 52-week and all-time highs. Recently rallied from support at its 200 DMA line. Reported earnings <strong>+12%</strong> on <strong>+15%</strong> sales revenues for the Jul &#39;14 quarter, its <strong>6</strong>th consecutive quarterly comparison with earnings below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). This Medical - Systems/Equipment firm was dropped from the Featured Stocks list on 4/15/05.<br><hr>10/14/2014 12:09:06 PM - Spiked to new 52-week and all-time highs with <strong>3</strong> consecutive volume-driven gains. Recently rallying from support at its 200 DMA line. Reported earnings <strong>+12%</strong> on <strong>+15%</strong> sales revenues for the Jul &#39;14 quarter, its <strong>6</strong>th consecutive quarterly comparison with earnings below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). This Medical - Systems/Equipment firm was dropped from the Featured Stocks list on 4/15/05.<br><hr>6/27/2014 12:41:16 PM - Still perched within close striking distance of its 52-week and all-time high. Rebounded from a dip below its 50 and 200 DMA lines during its consolidation since noted with caution in the 3/25/14 mid-day report. Reported earnings <strong>+18%</strong> on <strong>+14%</strong> sales revenues for the Apr &#39;14 quarter, its <strong>5</strong>th consecutive quarterly comparison with earnings below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). This Medical - Systems/Equipment firm was dropped from the Featured Stocks list on 4/15/05.<br><hr>6/20/2014 12:20:10 PM - Perched within close striking distance of its 52-week and all-time high. Rebounded from a dip below its 50 and 200 DMA lines during its consolidation since last noted with caution in the 3/25/14 mid-day report. Reported earnings <strong>+18%</strong> on <strong>+14%</strong> sales revenues for the Apr &#39;14 quarter, its <strong>5</strong>th consecutive quarterly comparison with earnings below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). This Medical - Systems/Equipment firm was dropped from the Featured Stocks list on 4/15/05.<br><hr>3/25/2014 1:50:48 PM - Perched within close striking distance of prior highs and its 52-week high. Rebounded from below its 50 DMA line with a streak of <strong>7</strong> gains marked by ever-increasing volume. Reported earnings <strong>+13%</strong> on <strong>+12%</strong> sales revenues for the Jan &#39;14 quarter. Found support at its 200 DMA line during its consolidation since noted in the 12/13/13 mid-day report with caution - <em>&quot;It has earned high ranks and its prior quarterly and annual earnings (<strong>C</strong> and <strong>A</strong> criteria) history had been strong, however, quarterly earnings comparisons showed worrisome deceleration while increasing by <strong>+62%</strong>, <strong>+53%</strong>, <strong>+26%</strong>, and <strong>+10%</strong> over the Jul &#39;12, Oct &#39;12, Jan &#39;13 and Apr &#39;13 periods, respectively. The Jul &#39;13 quarter was also below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria) of the fact-based system. This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>3/24/2014 12:10:18 PM - Perched within close striking distance of prior highs and its 52-week high. Rebounded from below its 50 DMA line with a streak of <strong>6</strong> gains marked by ever-increasing volume. Reported earnings <strong>+13%</strong> on <strong>+12%</strong> sales revenues for the Jan &#39;14 quarter. Found support at its 200 DMA line during its consolidation since noted in the 12/13/13 mid-day report with caution - <em>&quot;It has earned high ranks and its prior quarterly and annual earnings (<strong>C</strong> and <strong>A</strong> criteria) history had been strong, however, quarterly earnings comparisons showed worrisome deceleration while increasing by <strong>+62%</strong>, <strong>+53%</strong>, <strong>+26%</strong>, and <strong>+10%</strong> over the Jul &#39;12, Oct &#39;12, Jan &#39;13 and Apr &#39;13 periods, respectively. The Jul &#39;13 quarter was also below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria) of the fact-based system. This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>3/21/2014 12:12:45 PM - Rebounding from below its 50 DMA line with a streak of <strong>6</strong> gains marked by ever-increasing volume. Reported earnings <strong>+13%</strong> on <strong>+12%</strong> sales revenues for the Jan &#39;14 quarter. Found support at its 200 DMA line during its consolidation since last noted in the 12/13/13 mid-day report with caution - <em>&quot;It has earned high ranks and its prior quarterly and annual earnings (<strong>C</strong> and <strong>A</strong> criteria) history had been strong, however, quarterly earnings comparisons showed worrisome deceleration while increasing by <strong>+62%</strong>, <strong>+53%</strong>, <strong>+26%</strong>, and <strong>+10%</strong> over the Jul &#39;12, Oct &#39;12, Jan &#39;13 and Apr &#39;13 periods, respectively. The Jul &#39;13 quarter was also below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria) of the fact-based system. This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>12/13/2013 11:57:36 AM - Slumped below its 50 DMA line with a streak of <strong>7</strong> losses marked by above average volume in the span of <strong>8</strong> sessions. Reported earnings <strong>+17%</strong> on <strong>+19%</strong> sales revenues for the Oct &#39;13 quarter. Held its ground stubbornly and made gradual progress since noted in the 10/07/13 mid-day report with caution - <em>&quot;It has earned high ranks and its prior quarterly and annual earnings (<strong>C</strong> and <strong>A</strong> criteria) history had been strong, however, quarterly earnings comparisons showed worrisome deceleration while increasing by <strong>+62%</strong>, <strong>+53%</strong>, <strong>+26%</strong>, and <strong>+10%</strong> over the Jul &#39;12, Oct &#39;12, Jan &#39;13 and Apr &#39;13 periods, respectively. The Jul &#39;13 quarter was also below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria) of the fact-based system. This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>12/12/2013 12:29:08 PM - Slumping below its 50 DMA line with a streak of <strong>7</strong> losses in the span of <strong>8</strong> sessions. Reported earnings <strong>+17%</strong> on <strong>+19%</strong> sales revenues for the Oct &#39;13 quarter. Held its ground stubbornly and made gradual progress since noted in the 10/07/13 mid-day report with caution - <em>&quot;It has earned high ranks and its prior quarterly and annual earnings (<strong>C</strong> and <strong>A</strong> criteria) history had been strong, however, quarterly earnings comparisons showed worrisome deceleration while increasing by <strong>+62%</strong>, <strong>+53%</strong>, <strong>+26%</strong>, and <strong>+10%</strong> over the Jul &#39;12, Oct &#39;12, Jan &#39;13 and Apr &#39;13 periods, respectively. The Jul &#39;13 quarter was also below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria) of the fact-based system. This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>12/9/2013 12:19:25 PM - Traded above average volume while retreating from its new 52-week high last week, slumping near its 50 DMA line. Reported earnings <strong>+17%</strong> on <strong>+19%</strong> sales revenues for the Oct &#39;13 quarter. Held its ground stubbornly and made gradual progress since noted in the 10/07/13 mid-day report with caution - <em>&quot;It has earned high ranks and its prior quarterly and annual earnings (<strong>C</strong> and <strong>A</strong> criteria) history had been strong, however, quarterly earnings comparisons showed worrisome deceleration while increasing by <strong>+62%</strong>, <strong>+53%</strong>, <strong>+26%</strong>, and <strong>+10%</strong> over the Jul &#39;12, Oct &#39;12, Jan &#39;13 and Apr &#39;13 periods, respectively. The Jul &#39;13 quarter was also below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria) of the fact-based system. This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>12/5/2013 12:18:34 PM - Traded above average volume while retreating from its new 52-week high hit last week. Held its ground stubbornly and made gradual progress since last noted in the 10/07/13 mid-day report with caution - <em>&quot;It has earned high ranks and its prior quarterly and annual earnings (<strong>C</strong> and <strong>A</strong> criteria) history had been strong, however, quarterly earnings comparisons showed worrisome deceleration while increasing by <strong>+62%</strong>, <strong>+53%</strong>, <strong>+26%</strong>, and <strong>+10%</strong> over the Jul &#39;12, Oct &#39;12, Jan &#39;13 and Apr &#39;13 periods, respectively. The Jul &#39;13 quarter was also below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria) of the fact-based system. This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>10/7/2013 12:10:59 PM - Powered to new 52-week high territory with considerable volume-driven gains last week. Prior mid-day reports cautioned members - <em>&quot;It has earned high ranks and its prior quarterly and annual earnings (<strong>C</strong> and <strong>A</strong> criteria) history had been strong, however, quarterly earnings comparisons showed worrisome deceleration while increasing by <strong>+62%</strong>, <strong>+53%</strong>, <strong>+26%</strong>, and <strong>+10%</strong> over the Jul &#39;12, Oct &#39;12, Jan &#39;13 and Apr &#39;13 periods, respectively. The Jul &#39;13 quarter was also below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria) of the fact-based system. This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>9/30/2013 12:10:41 PM - Powering to new 52-week high territory with another considerable volume-driven gain. The 9/27/13 mid-day report cautioned members - <em>&quot;It has earned high ranks and its prior quarterly and annual earnings (<strong>C</strong> and <strong>A</strong> criteria) history had been strong, however, quarterly earnings comparisons showed worrisome deceleration while increasing by <strong>+62%</strong>, <strong>+53%</strong>, <strong>+26%</strong>, and <strong>+10%</strong> over the Jul &#39;12, Oct &#39;12, Jan &#39;13 and Apr &#39;13 periods, respectively. The Jul &#39;13 quarter was also below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria) of the fact-based system. This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>9/27/2013 11:59:12 AM - Perched at its 52-week high today after a considerable volume-driven gain on he prior session. It has earned high ranks and its prior quarterly and annual earnings (<strong>C</strong> and <strong>A</strong> criteria) history had been strong, however, quarterly earnings comparisons showed worrisome deceleration while increasing by <strong>+62%</strong>, <strong>+53%</strong>, <strong>+26%</strong>, and <strong>+10%</strong> over the Jul &#39;12, Oct &#39;12, Jan &#39;13 and Apr &#39;13 periods, respectively. The Jul &#39;13 quarter was also below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria) of the fact-based system. This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.<br><hr>9/20/2013 12:27:04 PM - Perched at its 52-week high today after recent gains with near average volume conviction. It has earned high ranks and its prior quarterly and annual earnings (<strong>C</strong> and <strong>A</strong> criteria) history had been strong, however, quarterly earnings comparisons showed worrisome deceleration while increasing by <strong>+62%</strong>, <strong>+53%</strong>, <strong>+26%</strong>, and <strong>+10%</strong> over the Jul &#39;12, Oct &#39;12, Jan &#39;13 and Apr &#39;13 periods, respectively. The latest quarter was below the +25% minimum guideline (<strong>C</strong> criteria) of the fact-based system. This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.<br><hr>2/6/2013 12:01:49 PM - Perched near its 52-week high today after recent gains with greater volume conviction. Held its ground after rallying above previously stubborn resistance in the <strong>$28</strong> area with volume-driven gains, and it is extended from any sound base. It has earned very high ranks by its strong quarterly and annual earnings (<strong>C</strong> and <strong>A</strong> criteria) history. However, quarterly sales revenues increases versus the year ago period have shown worrisome deceleration while <strong>+20%</strong>, <strong>+18%</strong>, <strong>+15%</strong>, and <strong>+7%</strong> over Jan, Apr, Jul, and Oct &#39;12, respectively . This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.<br><hr>2/1/2013 12:14:39 PM - Pulling back this week on higher volume after recently wedging to new highs with gains lacking great volume conviction. Held its ground after rallying above previously stubborn resistance in the <strong>$28</strong> area with volume-driven gains, and it is extended from any sound base. It has earned very high ranks by its strong quarterly and annual earnings (<strong>C</strong> and <strong>A</strong> criteria) history. However, quarterly sales revenues increases versus the year ago period have shown worrisome deceleration while <strong>+20%</strong>, <strong>+18%</strong>, <strong>+15%</strong>, and <strong>+7%</strong> over Jan, Apr, Jul, and Oct &#39;12, respectively . This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.<br><hr>1/28/2013 11:55:40 AM - Pulling back today on higher volume after recently wedging to new highs with gains lacking great volume conviction. Held its ground after rallying above previously stubborn resistance in the <strong>$28</strong> area with volume-driven gains, and it is extended from any sound base. It has earned very high ranks by its strong quarterly and annual earnings (<strong>C</strong> and <strong>A</strong> criteria) history. However, quarterly sales revenues increases versus the year ago period have shown worrisome deceleration while <strong>+20%</strong>, <strong>+18%</strong>, <strong>+15%</strong>, and <strong>+7%</strong> over Jan, Apr, Jul, and Oct &#39;12, respectively . This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.<br><hr>12/21/2012 12:16:49 PM - Holding its ground while enduring mild distributional pressure after rallying above previously stubborn resistance in the <strong>$28</strong> area with volume-driven gains, and it may be forming an advanced &quot;<strong>3</strong>-weeks tight&quot; base. It has earned very high ranks by its strong quarterly and annual earnings (<strong>C</strong> and <strong>A</strong> criteria) history. However, quarterly sales revenues increases versus the year ago period have shown worrisome deceleration while <strong>+20%</strong>, <strong>+18%</strong>, <strong>+15%</strong>, and <strong>+7%</strong> over Jan, Apr, Jul, and Oct &#39;12, respectively . This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.<br><hr>12/10/2012 12:17:17 PM - Inching above previously stubborn resistance in the <strong>$28</strong> area with above average volume behind today&#39;s <strong>3</strong>rd consecutive gain. The 12/07/12 mid-day report noted that its Relative Strength line was higher in prior months. Found support at its 200 DMA line and built a big base-on-base type pattern since noted in the 6/15/12 mid-day report. It has earned very high ranks by its strong quarterly and annual earnings (<strong>C</strong> and <strong>A</strong> criteria) history. However, sales revenues increases versus the year ago period have shown worrisome deceleration while <strong>+20%</strong>, <strong>+18%</strong>, <strong>+15%</strong>, and <strong>+7%</strong> over the Jan, Apr, Jul, and Oct &#39;12, respectively . This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.<br><hr>12/7/2012 12:23:22 PM - Its Relative Strength line was higher in prior months than it is today, meanwhile it is now inching above previously stubborn Resistance in the <strong>$28</strong> area. Found support at its 200 DMA line and built a big base-on-base type pattern since last noted in the 6/15/12 mid-day report. It has earned very high ranks by its strong quarterly and annual earnings (<strong>C</strong> and <strong>A</strong> criteria) history. However, sales revenues increases versus the year ago period have shown worrisome deceleration while <strong>+20%</strong>, <strong>+18%</strong>, <strong>+15%</strong>, and <strong>+7%</strong> over the Jan, Apr, Jul, and Oct &#39;12, respectively . This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.<br><hr>6/15/2012 12:02:03 PM - Perched at its 52-week high after volume-driven gains. Noted last week while rebounding from below its 50 DMA line and rising above the mid-point of a &quot;double bottom&quot; base pattern. Reported earnings <strong>+58%</strong> on <strong>+18%</strong> sales revenues for the quarter ended April 30, 2012 versus the year ago period. Prior mid-day reports noted - <em>&quot;Do not be confused by a <strong>3:2</strong> share split impacting prices effective 2/02/12. Reported earnings <strong>+32%</strong> on <strong>+20%</strong> sales revenues for the quarter ended January 31, 2012 versus the year ago period. Its annual earnings (the <strong>A</strong> criteria) history has been strong in recent years, however the prior <strong>7</strong> quarterly comparisons through Oct &#39;11 showed earnings increases below the <strong>+25%</strong> guideline. This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>6/12/2012 12:07:35 PM - Paused after reaching a new 52-week high with volume-driven gains. Noted last week while rebounding from below its 50 DMA line and rising above the mid-point of a &quot;double bottom&quot; base pattern. Reported earnings <strong>+58%</strong> on <strong>+18%</strong> sales revenues for the quarter ended April 30, 2012 versus the year ago period. Prior mid-day reports noted - <em>&quot;Do not be confused by a <strong>3:2</strong> share split impacting prices effective 2/02/12. Reported earnings <strong>+32%</strong> on <strong>+20%</strong> sales revenues for the quarter ended January 31, 2012 versus the year ago period. Its annual earnings (the <strong>A</strong> criteria) history has been strong in recent years, however the prior <strong>7</strong> quarterly comparisons through Oct &#39;11 showed earnings increases below the <strong>+25%</strong> guideline. This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>6/8/2012 12:10:19 PM - Challenging its 52-week high with today&#39;s gain. On the prior session it gapped up for a considerable gain, rebounding from below its 50 DMA line and rising above the mid-point of a &quot;double bottom&quot; base pattern. Reported earnings <strong>+58%</strong> on <strong>+18%</strong> sales revenues for the quarter ended April 30, 2012 versus the year ago period. Prior mid-day reports noted - <em>&quot;Do not be confused by a <strong>3:2</strong> share split impacting prices effective 2/02/12. Reported earnings <strong>+32%</strong> on <strong>+20%</strong> sales revenues for the quarter ended January 31, 2012 versus the year ago period. Its annual earnings (the <strong>A</strong> criteria) history has been strong in recent years, however the prior <strong>7</strong> quarterly comparisons through Oct &#39;11 showed earnings increases below the <strong>+25%</strong> guideline. This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>6/7/2012 11:59:46 AM - Gapped up today for a considerable gain, rebounding from below its 50 DMA line and rising above the mid-point of a &quot;double bottom&quot; base pattern. Reported earnings <strong>+58%</strong> on <strong>+18%</strong> sales revenues for the quarter ended April 30, 2012 versus the year ago period. Last noted in the 3/26/12 mid-day report - <em>&quot;Do not be confused by a <strong>3:2</strong> share split impacting prices effective 2/02/12. Reported earnings <strong>+32%</strong> on <strong>+20%</strong> sales revenues for the quarter ended January 31, 2012 versus the year ago period. Its annual earnings (the <strong>A</strong> criteria) history has been strong in recent years, however the prior <strong>7</strong> quarterly comparisons through Oct &#39;11 showed earnings increases below the <strong>+25%</strong> guideline. This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>3/26/2012 12:21:19 PM - Recently inching to new 52-week highs with a spurt of volume-driven gains. Prior mid-day reports noted - <em>&quot;Do not be confused by a <strong>3:2</strong> share split impacting prices effective 2/02/12. Reported earnings <strong>+32%</strong> on <strong>+20%</strong> sales revenues for the quarter ended January 31, 2012 versus the year ago period. Its annual earnings (the <strong>A</strong> criteria) history has been strong in recent years, however the prior <strong>7</strong> quarterly comparisons through Oct &#39;11 showed earnings increases below the <strong>+25%</strong> guideline. This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>3/23/2012 12:29:10 PM - Recently inching to new 52-week highs with a spurt of volume-driven gains. Last noted in the 3/09/12 mid-day report - <em>&quot;Do not be confused by a <strong>3:2</strong> share split impacting prices effective 2/02/12. Reported earnings <strong>+32%</strong> on <strong>+20%</strong> sales revenues for the quarter ended January 31, 2012 versus the year ago period. Its annual earnings (the <strong>A</strong> criteria) history has been strong in recent years, however the prior <strong>7</strong> quarterly comparisons through Oct &#39;11 showed earnings increases below the <strong>+25%</strong> guideline. This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>3/9/2012 12:04:37 PM - Rebounding from below its 50 DMA line this week and approaching its 52-week high with a <strong>3</strong>rd consecutive volume-driven gain today. Do not be confused by a <strong>3:2</strong> share split impacting prices effective 2/02/12. Reported earnings <strong>+32%</strong> on <strong>+20%</strong> sales revenues for the quarter ended January 31, 2012 versus the year ago period. Its annual earnings (the <strong>A</strong> criteria) history has been strong in recent years, however the prior <strong>7</strong> quarterly comparisons through Oct &#39;11 showed earnings increases below the <strong>+25%</strong> guideline. This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.<br><hr>2/7/2012 11:52:17 AM - Pulling back further today from the new 52-week high hit on 2/03/12 after <strong>4</strong> consecutive volume-driven gains. Do not be confused by a <strong>3:2</strong> share split impacting prices effective 2/02/12 when reviewing. Reported earnings <strong>+21%</strong> on <strong>+30%</strong> sales revenues for the quarter ended October 31, 2011 versus the year ago period and it found support near its 50 &amp; 200 DMA lines during its consolidation since noted in the 11/01/11 mid-day report - <em>&quot;Its annual earnings (the <strong>A</strong> criteria) history has been strong in recent years, however the past <strong>6</strong> quarterly comparisons through July &#39;11 showed earnings increases below the <strong>+25%</strong> guideline. This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>2/6/2012 12:25:56 PM - Pulling back today from the new 52-week high hit on the prior session after <strong>4</strong> consecutive volume-driven gains. Do not be confused by a <strong>3:2</strong> share split impacting prices effective 2/02/12 when reviewing. Reported earnings <strong>+21%</strong> on <strong>+30%</strong> sales revenues for the quarter ended October 31, 2011 versus the year ago period and it found support near its 50 &amp; 200 DMA lines during its consolidation since noted in the 11/01/11 mid-day report - <em>&quot;Its annual earnings (the <strong>A</strong> criteria) history has been strong in recent years, however the past <strong>6</strong> quarterly comparisons through July &#39;11 showed earnings increases below the <strong>+25%</strong> guideline. This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>2/3/2012 12:50:57 PM - Hitting another new 52-week high with today&#39;s <strong>4</strong>th consecutive volume-driven gain. Do not be confused by a <strong>3:2</strong> share split impacting prices effective 2/02/12 when reviewing. Reported earnings <strong>+21%</strong> on <strong>+30%</strong> sales revenues for the quarter ended October 31, 2011 versus the year ago period and it found support near its 50 &amp; 200 DMA lines during its consolidation since noted in the 11/01/11 mid-day report - <em>&quot;Its annual earnings (the <strong>A</strong> criteria) history has been strong in recent years, however the past <strong>6</strong> quarterly comparisons through July &#39;11 showed earnings increases below the <strong>+25%</strong> guideline. This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>1/10/2012 12:08:49 PM - Hitting a new 52-week high today with a <strong>3</strong>rd consecutive volume-driven gain. Reported earnings <strong>+21%</strong> on <strong>+30%</strong> sales revenues for the quarter ended October 31, 2011 versus the year ago period and it found support near its 50 &amp; 200 DMA lines during its consolidation since last noted in the 11/01/11 mid-day report - <em>&quot;Its annual earnings (the <strong>A</strong> criteria) history has been strong in recent years, however the past <strong>6</strong> quarterly comparisons through July &#39;11 showed earnings increases below the <strong>+25%</strong> guideline. This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>11/1/2011 12:35:57 PM - Holding its ground near its 52-week high since last noted in the 10/27/11 mid-day report after a gap up - <em>&quot;Its annual earnings (the <strong>A</strong> criteria) history has been strong in recent years, however the past <strong>6</strong> quarterly comparisons through July &#39;11 showed earnings increases below the <strong>+25%</strong> guideline. This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.&quot; </em><br><hr>10/27/2011 12:03:51 PM - Gapped up today, quickly approaching its 52-week high. Its annual earnings (the <strong>A</strong> criteria) history has been strong in recent years, however the past <strong>6</strong> quarterly comparisons through July &#39;11 showed earnings increases below the <strong>+25%</strong> guideline. This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.<br><hr>7/6/2011 12:32:38 PM - Approaching its 52-week high today while on track for its <strong>5</strong>th consecutive weekly gain. Its annual earnings (the <strong>A</strong> criteria) history has been strong in recent years, however the past <strong>5</strong> quarterly comparisons through April &#39;11 showed earnings increases below the <strong>+25%</strong> guideline. This Medical - Systems/Equipment firm survived but failed to impress since dropped from the Featured Stocks list on 4/15/05.<br><hr>6/26/2009 12:21:39 PM - Hit a new 52-week high today.   Its up and down annual earnings (the <strong>A</strong> criteria) history and lack of sales revenues growth are fundamental flaws  with respect to the investment system&#39;s criteria.    This Medical - Systems/Equipment firm&#39;s shares have struggled since  the stock was dropped from the  Featured Stocks list  on 4/15/05.<br><hr>4/16/2005 - Gaping down and still trading under 50 DMA. (CANSLIM.net daily coverage was suspended 4/15/05.)<br><hr>4/15/2005 10:56:32 AM - G - Gaping down and still trading under 50 DMA. (CANSLIM.net daily coverage will be suspended.)                                                                                                                                                                                                                                                                                                                                                                                                                     <br><hr>4/14/2005 3:19:17 PM - G - Still trading under 50 DMA.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     <br><hr>4/12/2005 3:31:03 PM - G - Impressive reversal from session lows halts four day plunge.                                                                                                                                                                                                                                                                                                                                                                                                                                                    <br><hr>4/11/2005 2:22:42 PM - G - Now breaking 50 DMA after two consecutive days of declines. Support near $25.                                                                                                                                                                                                                                                                                                                                                                                                                                   <br><hr>4/11/2005 11:49:55 AM - G - Now breaking 50 DMA after two consecutive days of declines.                                                                                                                                                                                                                                                                                                                                                                                                                                                     <br><hr>4/8/2005 2:03:36 PM - G - Sell off on above average volume yet holding above 50 DMA. No news found at this time.                                                                                                                                                                                                                                                                                                                                                                                                                          <br><hr>4/7/2005 4:18:07 PM - G - Above average slide today negating recent advance. Support at $28 of recent base.                                                                                                                                                                                                                                                                                                                                                                                                                               <br><hr>4/7/2005 11:54:07 AM - G - Moring pull back a bit after yesterday's nice advance. Well above initial support ($28) of recent base.                                                                                                                                                                                                                                                                                                                                                                                                         <br><hr>4/6/2005 4:13:11 PM - Continues recent advance and ends day with a new high close on above avg vol.                                                                                                                                                                                                                                                                                                                                                                                                                                       <br><hr>4/6/2005 12:25:55 PM - Best in pretty good group. Small number of shares outstanding. Featured in Sept CANSLIM.net News. First highlighted on 8/31/04 at $17.65 (adjusted for a 3/2 split). No base to buy from.                                                                                                                                                                                                                                                                                                                           <br><hr>4/5/2005 12:32:36 PM - L in good group. Small number of shares outstanding. Featured in Sept CANSLIM.net News. First highlighted on 8/31/04 at $17.65 (adjusted for a 3/2 split). No base to buy from.                                                                                                                                                                                                                                                                                                                                     <br><hr>4/4/2005 12:22:50 PM - Best in good group. Small number of shares outstanding. Featured in Sept CANSLIM.net News. First highlighted on 8/31/04 at $17.65 (adjusted for a 3/2 split). No base to buy from.                                                                                                                                                                                                                                                                                                                                  <br><hr>3/23/2005 12:39:32 PM - Best in good group. Small number of shares outstanding. Featured in Sept CANSLIM.net News. First highlighted on 8/31/04 at $17.65 (adjusted for a 3/2 split). Recent breakout failed. Continues basing.                                                                                                                                                                                                                                                                                                             <br><hr>3/23/2005 10:05:20 AM - G - Down this morning on above average volume after closing yesterday at a new high. No news found at this time. Strong support near $25.                                                                                                                                                                                                                                                                                                                                                                           <br><hr>3/22/2005 10:24:31 AM - G - Breaking out to new high ground. Starting to get a little extended to be a new purchase.                                                                                                                                                                                                                                                                                                                                                                                                                        <br><hr>3/7/2005 12:29:36 PM - Y- L in  good group. Small number of shares outstanding. Featured in Sept CANSLIM.net News. First highlighted on 8/31/04 at $17.65 (adjusted for a 3/2 split). Spent the past three months basing. Now Breaking out with a new PP=$27.09 MB= $28.44.                                                                                                                                                                                                                                                                <br><hr>3/3/2005 12:27:24 PM - Y- L in  good group. Small number of shares outstanding. Featured in Sept CANSLIM.net News. First highlighted on 8/31/04 at $17.65 (adjusted for a 3/2 split). Spent the past three months basing. Now Breaking out with a new PP=$27.09 MB= $28.44.                                                                                                                                                                                                                                                                <br><hr>3/2/2005 12:35:58 PM - G/B - L in  good group. Small number of shares outstanding. Featured in Sept CANSLIM.net News. First highlighted on 8/31/04 at $26.48. Currently, well entrenched in a three month base.                                                                                                                                                                                                                                                                                                                            <br><hr>1/3/2005 12:37:59 PM - G/B - L in decent group. Small number of shares outstanding. Featured in Sept CANSLIM.net News. First highlighted on 8/31/04 at $26.48. Now too ET from a sound base of support at this point to be considered buyable under the guidelines.                                                                                                                                                                                                                                                                        <br><hr>12/30/2004 12:21:04 PM - G/B - L in decent group. Poised to close at new 52 week high. Small number of shares outstanding. Featured in Sept CANSLIM.net News. First highlighted on 8/31/04 at $26.48. Now too ET from a sound base of support at this point to be considered buyable under the guidelines.                                                                                                                                                                                                                                   <br><hr>12/28/2004 12:28:52 PM - G/B - L in decent group. Negative action today. Small number of shares outstanding. Featured in Sept CANSLIM.net News. First highlighted on 8/31/04 at $26.48. Now too ET from a sound base of support at this point to be considered buyable under the guidelines.                                                                                                                                                                                                                                                 <br><hr>12/27/2004 12:21:59 PM - G/B - L in decent group. Gapped higher today. Small number of shares outstanding. Featured in Sept CANSLIM.net News. First highlighted on 8/31/04 at $26.48. Now too ET from a sound base of support at this point to be considered buyable under the guidelines.                                                                                                                                                                                                                                                   <br><hr>12/23/2004 12:33:25 PM - G/B - L in decent group. Small number of shares outstanding. Featured in Sept CANSLIM.net News. First highlighted on 8/31/04 at $26.48. Now too ET from a sound base of support at this point to be considered buyable under the guidelines.                                                                                                                                                                                                                                                                        <br><hr>12/23/2004 12:33:02 PM - G/B - L in decent group. Small number of shares outstanding. Featured in Sept CANSLIM.net News. First highlighted on 8/31/04 at $26.48. Now too ET from a sound base of support at this point to be considered buyable under the guidelines.                                                                                                                                                                                                                                                                        <br><hr>12/23/2004 12:32:35 PM - G/B - L in decent group. Small number of shares outstanding. Featured in Sept CANSLIM.net News. First highlighted on 8/31/04 at $26.48. Now too ET from a sound base of support at this point to be considered buyable under the guidelines.                                                                                                                                                                                                                                                                        <br><hr>12/22/2004 12:14:00 PM - G/B - L in decent group. Small number of shares outstanding. Featured in Sept CANSLIM.net News. First highlighted on 8/31/04 at $26.48. Now too ET from a sound base of support at this point to be considered buyable under the guidelines.                                                                                                                                                                                                                                                                        <br><hr>12/21/2004 12:40:25 PM - G/B - L in decent group. Small number of shares outstanding. Featured in Sept CANSLIM.net News. First highlighted on 8/31/04 at $26.48. Now too ET from a sound base of support at this point to be considered buyable under the guidelines.                                                                                                                                                                                                                                                                        <br><hr>12/20/2004 12:17:51 PM - G/B - L in decent group. Small number of shares outstanding. Featured in Sept CANSLIM.net News. First highlighted on 8/31/04 at $26.48. Now too ET from a sound base of support at this point to be considered buyable under the guidelines.                                                                                                                                                                                                                                                                        <br><hr>12/17/2004 12:33:40 PM - G/B - L in decent group. Small number of shares outstanding. Featured in Sept CANSLIM.net News. First highlighted on 8/31/04 at $26.48. Now too ET from a sound base of support at this point to be considered buyable under the guidelines.                                                                                                                                                                                                                                                                        <br><hr>12/2/2004 12:24:01 PM - G/B - L in decent group. Small number of shares outstanding. Featured in Sept CANSLIM.net News. First highlighted on 8/31/04 at $26.48. Now too ET from a sound base of support at this point to be considered buyable under the guidelines.                                                                                                                                                                                                                                                                        <br><hr>9/1/2004 1:00:00 PM - Y/B - L in decent group. Impressive recent move from 50 DMA. Small number of shares outstanding. Just featured in Sept CANSLIM.net News.                                                                                                                                                                                                                                                                                                                                                                            <br><hr>8/31/2004 1:00:00 PM - Y - L in decent group. Impressive recent move from 50 DMA. Small number of shares outstanding.                                                                                                                                                                                                                                                                                                                                                                                                                      <br><hr>7/14/2004 1:00:00 PM - Best in pretty good group. Base questionable at this point and quickly getting too ET to be buyable under the guidelines.                                                                                                                                                                                                                                                                                                                                                                                           <br><hr>7/13/2004 1:00:00 PM - Best in pretty good group. Base questionable at this point and quickly getting too ET to be buyable under the guidelines.                                                                                                                                                                                                                                                                                                                                                                                           <br><hr>7/12/2004 1:00:00 PM - Best in pretty good group. Base questionable at this point and quickly getting too ET to be buyable under the guidelines.                                                                                                                                                                                                                                                                                                                                                                                           <br><hr>7/8/2004 1:00:00 PM - Best in pretty good group. Base questionable at this point and quickly getting too ET to be buyable under the guidelines.                                                                                                                                                                                                                                                                                                                                                                                           <br><hr>7/7/2004 1:00:00 PM - Best in pretty good group. Base questionable at this point and quickly getting too ET to be buyable under the guidelines.                                                                                                                                                                                                                                                                                                                                                                                           <br><hr>7/6/2004 1:00:00 PM - Best in pretty good group. Base questionable at this point and quickly getting too ET to be buyable under the guidelines.                                                                                                                                                                                                                                                                                                                                                                                           <br><hr>7/1/2004 1:00:00 PM - Leader in pretty good group. Base questionable at this point.                                                                                                                                                                                                                                                                                                                                                                                                                                                       <br><hr>7/1/2004 1:00:00 PM - Leader in decent group. Now base building since recent BV BO.                                                                                                                                                                                                                                                                                                                                                                                                                                                       <br><hr>6/30/2004 1:00:00 PM - Leader in decent group. Way too ET from $18 base to be buyable under the guidelines.                                                                                                                                                                                                                                                                                                                                                                                                                                <br><hr>6/25/2004 1:00:00 PM - Leader in decent group. Way too ET from $18 base to be buyable under the guidelines.                                                                                                                                                                                                                                                                                                                                                                                                                                <br><hr>6/21/2004 1:00:00 PM - Leader in decent group. Way too ET from $18 base to be buyable under the guidelines.                                                                                                                                                                                                                                                                                                                                                                                                                                <br><hr>6/14/2004 1:00:00 PM - Leader in decent group. Way too ET from $18 base to be buyable under the guidelines.                                                                                                                                                                                                                                                                                                                                                                                                                                <br><hr>9/13/2004 4:15:00 PM - Broke 50 DMA on above average volume, stopping short of July-Aug lows and improving from its intra-day lows. Still, that makes four losses on volume above average in the past eight sessions.  Has not broken above pivot point since featured so should have never been purchased under the guidelines. (CANSLIM.net daily coverage will be suspended.)                                                                                                                                                           <br><hr>9/10/2004 4:15:00 PM - Closed within pennies of its 50 DMA. Has not broken above pivot point since featured, but should trade 50% above average for a legit breakout. Today it did violate a steep 3-month upward trendline, a cause for some concern.                                                                                                                                                                                                                                                                                     <br><hr>9/9/2004 4:15:00 PM - Ends session with a loss on lighter volume. Continues to form a pattern that resembles a cup-with-handle, with the recent pullback making an ideal downward sloping handle. Has not broken pivot point since featured, but should trade 50% above average for a legit breakout.                                                                                                                                                                                                                                     <br><hr>9/8/2004 4:15:00 PM - Decent up day though volume could have been better. Continues to form a pattern that resembles a cup-with-handle, with the recent pullback making an ideal downward sloping handle. Has not broken pivot point since featured, but should trade 50% above average for a legit breakout                                                                                                                                                                                                                              <br><hr>9/7/2004 4:15:00 PM - Loss with volume near average, finishing near session lows. Forming a pattern that resembles a cup-with-handle, with the recent pullback making an ideal downward sloping handle.  Has not broken pivot point since featured, but should trade 50% above average for a legit breakout.                                                                                                                                                                                                                              <br><hr>9/3/2004 4:15:00 PM - Decent gain today but on only half average volume.  Little resistance is standing in its way now as it lingers near highs.                                                                                                                                                                                                                                                                                                                                                                                          <br><hr>9/2/2004 4:15:00 PM - Continued weakness since yesterday's reversal, closing near the low end of its daily trading range with very low volume today. Annouced appointing new executives including new COO.                                                                                                                                                                                                                                                                                                                                <br><hr>9/1/2004 4:15:00 PM - Had gains to new high ground then reversed intra-day to become a loss, with the close near the low end of its daily trading range a cause for concern short-term. Annouced appointing new executives including new COO.                                                                                                                                                                                                                                                                                             <br><hr>